Literature DB >> 10504449

Infection of circulating CD34+ cells by HHV-8 in patients with Kaposi's sarcoma.

M Henry1, A Uthman, A Geusau, A Rieger, L Furci, A Lazzarin, P Lusso, E Tschachler.   

Abstract

Human herpesvirus type 8 (HHV-8) has been identified as the most likely candidate to be involved in the development of Kaposi's Sarcoma (KS). HHV-8 has been associated with all forms of KS, primary effusion lymphoma, and multicentric Castleman's disease and detected in various non-neoplastic cells. Its presence in cells of the different hemopoietic lineages has not yet been investigated in a comprehensive and systematic manner. In this study we searched for the presence of HHV-8 in different subpopulations of peripheral blood mononuclear cells (PBMC) from patients with classic and AIDS-associated KS, as well as from HIV-1 sero-positive and sero-negative persons without KS. Thirty-four samples of PBMC were isolated from 30 patients. Subpopulations were isolated with immunomagnetic beads. Polymerase chain reaction for HHV-8 DNA was performed on PBMC and subpopulations with a primer pair selected from ORF26 of the viral genome. Polymerase chain reaction products were subsequently Southern blotted and hybridized. In patients with KS, HHV-8 DNA was detected in nine of 11 (81%) CD19+ cells, four of 11 (36%) CD2+ cells, three of 11 (27%) CD14+ cells, and nine of 11 (81%) of the remaining depleted cell populations (DP) that contain CD34 positive cells. In a subsequent set of experiments HHV-8 DNA was detected in 10 of 12 (83%) CD34 positive cell fractions. All cell subpopulations from the non-KS group were HHV-8 negative, with the exception of one positive B cell sample obtained from an HIV-infected patient. Our data demonstrate that in peripheral blood HHV-8 is detectable not only in CD19+ cells, as previously reported, but also in other cells, including T cells, monocytes, and cells devoid of specific lineage markers. We also show for the first time that CD34+ cells in peripheral blood of KS patients are a predominant HHV-8-harboring population, suggesting that they represent an additional important reservoir for this virus in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10504449     DOI: 10.1046/j.1523-1747.1999.00733.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  15 in total

1.  Immature and transitional B cells are latency reservoirs for a gammaherpesvirus.

Authors:  Carrie B Coleman; Michael S Nealy; Scott A Tibbetts
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice.

Authors:  Christopher H Parsons; Laura A Adang; Jon Overdevest; Christine M O'Connor; J Robert Taylor; David Camerini; Dean H Kedes
Journal:  J Clin Invest       Date:  2006-06-22       Impact factor: 14.808

3.  Induction of cell cycle arrest by human T-cell lymphotropic virus type 1 Tax in hematopoietic progenitor (CD34+) cells: modulation of p21cip1/waf1 and p27kip1 expression.

Authors:  Adam Tripp; Prabal Banerjee; Michelle Sieburg; Vicente Planelles; Fengzhi Li; Gerold Feuer
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  Establishment and maintenance of Kaposi's sarcoma-associated herpesvirus latency in B cells.

Authors:  Lei Chen; Michael Lagunoff
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin.

Authors:  Hsei-Wei Wang; Tyson V Sharp; Andrew Koumi; Georgy Koentges; Chris Boshoff
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

6.  Human herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immunodeficiency virus type 1 Tat.

Authors:  Shibani Pati; James S Foulke; Oxana Barabitskaya; Jynho Kim; B C Nair; David Hone; Jennifer Smart; Ricardo A Feldman; Marvin Reitz
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

7.  Fibrous Proliferations in Posttransplant Kaposi Sarcoma.

Authors:  Kevin M Adams; Philip Milam; Alejandro Gru; Benjamin H Kaffenberger
Journal:  J Clin Aesthet Dermatol       Date:  2021-06-01

8.  KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo.

Authors:  William Wu; Jeffrey Vieira; Nancy Fiore; Prabal Banerjee; Michelle Sieburg; Rosemary Rochford; William Harrington; Gerold Feuer
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

9.  Susceptibility of human fetal mesenchymal stem cells to Kaposi sarcoma-associated herpesvirus.

Authors:  Christopher H Parsons; Barbara Szomju; Dean H Kedes
Journal:  Blood       Date:  2004-07-06       Impact factor: 22.113

10.  Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation.

Authors:  Janet L Douglas; Jean K Gustin; Ashlee V Moses; Bruce J Dezube; Liron Pantanowitz
Journal:  Transl Biomed       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.